Ventana Medical Systems has entered into master collaboration agreement with Astellas Pharma to develop novel automated tissue diagnostics Read the full story

Immunomic Therapeutics and Astellas Pharma have entered into an exclusive license agreement for Japan to develop and commercialize JRC2-LAMP-vax Read the full story

Cytokinetics and Astellas Pharma announced an amendment to their collaboration agreement focused on the research, development and commercialization of skeletal muscle activators Read the full story

Astellas Pharma announced that its license agreement with Janssen Biotech, to develop and commercialize ASP015K, oral Janus Kinase (JAK) inhibitor, will end Read the full story

Proteostasis Therapeutics announced an R&D and commercialization pharma deal with Tokyo-based Astellas Pharma. Read the full story

QIAGEN announced a biotech partnership agreement with Astellas Pharma to develop and commercialize companion diagnostics paired with Astellas drugs for use in cancer and other diseases. Read the full story

Astellas Pharma announced a pharma alliance with an investigator at Harvard Medical School focused on discovering the pathologic mechanism for retinitis pigmentosa and identification of new therapeutic targets. Read the full story

Big pharma, Astellas is again partnering with Starlight Children's Foundation ("Starlight"), a leading global charity that partners with experts to improve the life and health of kids and families around the world through a unique blend of family-centered services from hospital to home. Read the full story

The term 'top pharma' can relate to the top pharmaceutical companies or the top 10 or 50... Read the full story

Astellas is a top pharmaceutical company based in Tokyo, Japan Read the full story